Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy.
Johnson DB, Estrada MV, Salgado R, Sanchez V, Doxie DB, Opalenik SR, Vilgelm AE, Feld E, Johnson AS, Greenplate AR, Sanders ME, Lovly CM, Frederick DT, Kelley MC, Richmond A, Irish JM, Shyr Y, Sullivan RJ, Puzanov I, Sosman JA, Balko JM.
Johnson DB, et al. Among authors: irish jm.
Nat Commun. 2016 Jan 29;7:10582. doi: 10.1038/ncomms10582.
Nat Commun. 2016.
PMID: 26822383
Free PMC article.